AAAAAA
Results: 201-225/265
Authors:
Kirby, R
Scher, H
Brawer, M
Citation: R. Kirby et al., Untitled, PROSTATE C, 1(6), 1998, pp. 288-288
Authors:
Gleave, M
Goldenberg, SL
Bruchovsky, N
Rennie, P
Citation: M. Gleave et al., Intermittent androgen suppression for prostate cancer: rationale and clinical experience, PROSTATE C, 1(6), 1998, pp. 289-296
Authors:
Klein, EA
Kupelian, PA
Witte, JS
Citation: Ea. Klein et al., Does a family history of prostate cancer result in more aggressive disease?, PROSTATE C, 1(6), 1998, pp. 297-300
Authors:
Polascik, TJ
Pearson, JD
Partin, AW
Citation: Tj. Polascik et al., Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer, PROSTATE C, 1(6), 1998, pp. 301-306
Authors:
Kolvenbag, GJCM
Furr, BJA
Blackledge, GRP
Citation: Gjcm. Kolvenbag et al., Receptor affinity and potency of non-steroidal antiandrogens: translation of preclinical findings into clinical activity, PROSTATE C, 1(6), 1998, pp. 307-314
Authors:
Guinan, P
Stewart, AK
Fremgen, AM
Menck, HR
Citation: P. Guinan et al., Patterns of care for metastatic carcinoma of the prostate gland: results of the American College of Surgeons' patient care evaluation study, PROSTATE C, 1(6), 1998, pp. 315-320
Authors:
Ravery, V
Lamotte, F
Hennequin, CH
Toublanc, M
Boccon-Gibod, L
Hermieu, JF
Delmas, V
Boccon-Gibod, L
Citation: V. Ravery et al., Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1-T2 prostate cancer, PROSTATE C, 1(6), 1998, pp. 321-325
Authors:
Roth, HJ
Stewart, SC
Brawer, MK
Citation: Hj. Roth et al., A comparison of three free and total PSA assays, PROSTATE C, 1(6), 1998, pp. 326-331
Authors:
Michel, MC
Mehlburger, L
Bressel, HU
Goepel, M
Citation: Mc. Michel et al., Comparison of tamsulosin efficacy in subgroups of patients with lower urinary tract symptoms, PROSTATE C, 1(6), 1998, pp. 332-335
Authors:
BELLDEGRUN A
Citation: A. Belldegrun, WHATS HOT IN THE PROSTATE, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 225-226
Authors:
KIRBY RS
Citation: Rs. Kirby, PCPD EDITORIAL, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 227-227
Authors:
LITWIN MS
PENSON DF
Citation: Ms. Litwin et Df. Penson, HEALTH-RELATED QUALITY-OF-LIFE IN MEN WITH PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 228-235
Authors:
GELDOF AA
VANHAARST EP
NEWLING DWW
Citation: Aa. Geldof et al., NEUROTROPHIC FACTORS IN PROSTATE AND PROSTATIC-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 236-241
Authors:
MOUL JW
MOONEYHAN RM
KAO TC
MCLEOD DG
CRUESS DF
Citation: Jw. Moul et al., PREOPERATIVE AND OPERATIVE FACTORS TO PREDICT INCONTINENCE, IMPOTENCEAND STRICTURE AFTER RADICAL PROSTATECTOMY, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 242-249
Authors:
BENAIM EA
MONTOYA JD
SABOORIAN MH
LITWILLER S
ROEHRBORN CG
Citation: Ea. Benaim et al., CHARACTERIZATION OF PROSTATE SIZE, PSA AND ENDOCRINE PROFILES IN PATIENTS WITH SPINAL-CORD INJURIES, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 250-255
Authors:
STENNER J
DEANTONI EP
ODONNELL C
STONE NN
MCLEOD DG
CRAWFORD ED
Citation: J. Stenner et al., PREVALENCE AND NATURAL-HISTORY OF URINARY SYMPTOMS IN A LONGITUDINAL NATIONAL PROSTATE-CANCER SCREENING (COMMUNITY-BASED) STUDY, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 256-261
Authors:
TORRING N
SORENSEN BS
BOSCH ST
KLOCKER H
NEXO E
Citation: N. Torring et al., AMPHIREGULIN IS EXPRESSED IN PRIMARY CULTURES OF PROSTATE MYOFIBROBLASTS, FIBROBLASTS, EPITHELIAL-CELLS, AND IN PROSTATE TISSUE, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 262-267
Authors:
BORRE M
STRAUSBOLGRON B
NERSTROM B
OVERGAARD J
Citation: M. Borre et al., IMMUNOHISTOCHEMICAL BCL-2 AND KI-67 EXPRESSION PREDICT SURVIVAL IN PROSTATE-CANCER PATIENTS FOLLOWED EXPECTANTLY, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 268-275
Authors:
LUKACS B
GRANGE JC
COMET D
MCCARTHY C
Citation: B. Lukacs et al., 3-YEAR PROSPECTIVE-STUDY OF 3228 CLINICAL BPH PATIENTS TREATED WITH ALFUZOSIN IN GENERAL-PRACTICE, PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 276-283
Authors:
PENSON DF
LITWIN MS
LUBECK DP
FLANDERS S
PASTA DJ
CARROLL PR
Citation: Df. Penson et al., TRANSITIONS IN HEALTH-RELATED QUALITY-OF-LIFE DURING THE FIRST 9 MONTHS AFTER DIAGNOSIS OF PROSTATE-CANCER (VOL 1, PG 134, 1998), PROSTATE CANCER AND PROSTATIC DISEASES, 1(5), 1998, pp. 284-284
Authors:
KIRBY RS
Citation: Rs. Kirby, BREAKING BAD-NEWS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(4), 1998, pp. 177-178
Authors:
KIRBY RS
WATSON A
NEWLING DWW
Citation: Rs. Kirby et al., PROSTATE-CANCER AND SEXUAL FUNCTION, PROSTATE CANCER AND PROSTATIC DISEASES, 1(4), 1998, pp. 179-184
Authors:
ASH D
BOTTOMLEY DM
CAREY BM
Citation: D. Ash et al., PROSTATE BRACHYTHERAPY, PROSTATE CANCER AND PROSTATIC DISEASES, 1(4), 1998, pp. 185-188
Authors:
NAITOH J
BELLDEGRUN A
Citation: J. Naitoh et A. Belldegrun, GENE-THERAPY FOR PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(4), 1998, pp. 189-196
Authors:
PARTIN AW
BRAWER MK
SUBONG ENP
KELLEY CA
COX JL
BRUZEK DJ
PANNEK J
MEYER GE
CHAN DW
Citation: Aw. Partin et al., PROSPECTIVE EVALUATION OF PERCENT FREE-PSA AND COMPLEXED-PSA FOR EARLY DETECTION OF PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(4), 1998, pp. 197-203